Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.

One drop of Miebo had no significant impact on presurgical corneal measurements taken within 60 minutes of instillation, ...

Menopausal women with larger waist circumference had a greater risk for death regardless of their BMI category, according to ...

Pediatric dermatologists must play an active role in treating obesity in children, according to a presenter at the Society ...

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

Infants exposed to household cleaning products 1 day or more per week during their first year of life were more likely to ...

Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...

In this Healio Video Perspective from the ARVO meeting, Michael Javaheri, MD, overviews real-world data on Eylea HD in ...

Latanoprostene bunod 0.024% significantly reduced IOP across patient groups and appeared well regarded among physicians and ...

The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...